Literature DB >> 27749362

Requirements for human natural killer cell development informed by primary immunodeficiency.

Emily M Mace1.   

Abstract

PURPOSE OF REVIEW: Human natural killer (NK) cell development is poorly understood; however, we gain important insight from cases of human primary immunodeficiency that affect the generation of mature human NK cell subsets. In this review, monogenic primary immunodeficiencies that highlight critical requirements for human NK cell development are discussed. RECENT
FINDINGS: Increased resolution in NK cell phenotyping has revealed NK cell deficiencies that affect the distribution of NK cell subsets found in peripheral blood. These, in addition to those that prevent the generation of mature NK cells, identify important requirements for the maturation and homeostasis of human NK cells. The serious and often life-threatening viral susceptibility that accompanies these highlights the nonredundant role that NK cells play in human health and disease.
SUMMARY: Human NK cell deficiency may occur in cases where NK cells are present in normal numbers but subsets are affected.

Entities:  

Mesh:

Year:  2016        PMID: 27749362     DOI: 10.1097/ACI.0000000000000317

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  3 in total

1.  Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.

Authors:  Mathieu Amand; Gilles Iserentant; Aurélie Poli; Marwan Sleiman; Virginie Fievez; Isaura Pilar Sanchez; Nicolas Sauvageot; Tatiana Michel; Nasséra Aouali; Bassam Janji; Claudia Milena Trujillo-Vargas; Carole Seguin-Devaux; Jacques Zimmer
Journal:  Front Immunol       Date:  2017-06-19       Impact factor: 7.561

2.  How I Manage Natural Killer Cell Deficiency.

Authors:  Jordan S Orange
Journal:  J Clin Immunol       Date:  2019-11-22       Impact factor: 8.317

3.  Phenotypic and Functional Changes in Peripheral Blood Natural Killer Cells in Crohn Disease Patients.

Authors:  Suzanne Samarani; Patrick Sagala; Prevost Jantchou; Guy Grimard; Christophe Faure; Colette Deslandres; Devendra K Amre; Ali Ahmad
Journal:  Mediators Inflamm       Date:  2020-02-19       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.